Rep. Michael Burgess has disclosed 26 buys and 44 sales since Jun 2023
House · R-TX
Rep. Michael Burgess's record
3 months after each buy, from the first price a copier could get.
22 buys since 2023 with 3 months of prices.
Bought most often
Every disclosure
Newest first. Members report amounts as ranges.
Best Buy Co Inc
Berkshire Hathaway Inc
Amazon.com Inc
Alphabet Inc
Advanced Micro Devices Inc
United Parcel Service Inc
CME Group Inc
The Chemours Co
AbbVie Inc
Cigna Corp
Blackstone Group Inc
Blackstone Group Inc
The Chemours Co
The Chemours Co
Berkshire Hathaway Inc
Amazon.com Inc
Amazon.com Inc
Alphabet Inc
AbbVie Inc
Blackstone Group Inc
About Michael Burgess
Michael C. Burgess, M.D., a Republican, represented Texas's 26th Congressional District in the U.S. House from 2003 to 2025, after practicing as an OB/GYN in North Texas for nearly three decades.( Born in 1950, he holds degrees from the University of North Texas, an M.D. from the University of Texas Medical School in Houston, and completed residency at Parkland Hospital; he served on the House Energy and Commerce Committee as top Republican on Oversight and Investigations, Republican Leader of the Health Subcommittee, and on Health, Energy and Environment, Consumer Protection and Commerce subcommittees, plus the Rules Committee and Joint Economic Committee, while chairing the Congressional Health Care Caucus.(
Burgess authored the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), repealing the Sustainable Growth Rate formula, and contributed to the 21st Century Cures Act, focusing on health care costs, opioid crisis, drug prices, and patient safety.( He advocated for transportation improvements, earning awards like House Legislator of the Year from the Multiple Sclerosis Society.( Public attention has noted his recent stock trades in ILMN, RY, UPS under STOCK Act disclosures, though specific controversy details are limited in available records; he retired after 2025.(
Written by Perplexity from public sources.
Disclosures come from STOCK Act filings. Returns start at the first open after a buy was disclosed. Not investment advice.